These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 18451227

  • 1. Microdistribution of targeted, fluorescently labeled anti-carcinoembryonic antigen antibody in metastatic colorectal cancer: implications for radioimmunotherapy.
    Fidarova EF, El-Emir E, Boxer GM, Qureshi U, Dearling JL, Robson MP, Begent RH, Trott KR, Pedley RB.
    Clin Cancer Res; 2008 May 01; 14(9):2639-46. PubMed ID: 18451227
    [Abstract] [Full Text] [Related]

  • 2. Intratumoral distribution of radiolabeled antibody and radioimmunotherapy in experimental liver metastases model of nude mouse.
    Sato N, Saga T, Sakahara H, Yao Z, Nakamoto Y, Zhang M, Kuroki M, Matsuoka Y, Iida Y, Konishi J.
    J Nucl Med; 1999 Apr 01; 40(4):685-92. PubMed ID: 10210230
    [Abstract] [Full Text] [Related]

  • 3. Predicting response to radioimmunotherapy from the tumor microenvironment of colorectal carcinomas.
    El Emir E, Qureshi U, Dearling JL, Boxer GM, Clatworthy I, Folarin AA, Robson MP, Nagl S, Konerding MA, Pedley RB.
    Cancer Res; 2007 Dec 15; 67(24):11896-905. PubMed ID: 18089820
    [Abstract] [Full Text] [Related]

  • 4. Initial experience evaluating 90yttrium-radiolabeled anti-carcinoembryonic antigen chimeric T84.66 in a phase I radioimmunotherapy trial.
    Wong JY, Williams LE, Yamauchi DM, Odom-Maryon T, Esteban JM, Neumaier M, Wu AM, Johnson DK, Primus FJ, Shively JE.
    Cancer Res; 1995 Dec 01; 55(23 Suppl):5929s-5934s. PubMed ID: 7493373
    [Abstract] [Full Text] [Related]

  • 5. [Influence of combination of low dosage 131I-labeled anti-carcinoembryonic antigen antibody C50 and 5-fluorouracil on tumor growth of colorectal cancer xenografts in nude mice].
    Zheng CX, Zhan WH, Cai SR, He YL, Lin ZJ.
    Ai Zheng; 2003 Apr 01; 22(4):354-7. PubMed ID: 12703987
    [Abstract] [Full Text] [Related]

  • 6. Pretargeting of carcinoembryonic antigen-expressing tumors with a biologically produced bispecific anticarcinoembryonic antigen x anti-indium-labeled diethylenetriaminepentaacetic acid antibody.
    van Schaijk FG, Oosterwijk E, Soede AC, Broekema M, Frielink C, McBride WJ, Goldenberg DM, Corstens FH, Boerman OC.
    Clin Cancer Res; 2005 Oct 01; 11(19 Pt 2):7130s-7136s. PubMed ID: 16203812
    [Abstract] [Full Text] [Related]

  • 7. Immunohistology of carcinoembryonic antigen (CEA)-expressing tumors grafted in nude mice after radioimmunotherapy with 131I-labeled bivalent hapten and anti-CEA x antihapten bispecific antibody.
    Gautherot E, Kraeber-Bodéré F, Daniel L, Fiche M, Rouvier E, Saï-Maurel C, Thedrez P, Chatal JF, Barbet J.
    Clin Cancer Res; 1999 Oct 01; 5(10 Suppl):3177s-3182s. PubMed ID: 10541361
    [Abstract] [Full Text] [Related]

  • 8. Combined immunohistochemical and autoradiographic analyses of antigen/antibody interactions in tumor xenograft models.
    DePalatis LR, Johnson KA, Kaplan DA.
    Lab Invest; 1991 Jul 01; 65(1):111-20. PubMed ID: 2072661
    [Abstract] [Full Text] [Related]

  • 9. Variables influencing tumor dosimetry in radioimmunotherapy of CEA-expressing cancers with anti-CEA and antimucin monoclonal antibodies.
    Behr TM, Sharkey RM, Juweid ME, Dunn RM, Ying Z, Zhang CH, Siegel JA, Goldenberg DM.
    J Nucl Med; 1997 Mar 01; 38(3):409-18. PubMed ID: 9074529
    [Abstract] [Full Text] [Related]

  • 10. Adjuvant 131I-anti-CEA-antibody radioimmunotherapy inhibits the development of experimental colonic carcinoma liver metastases.
    Mahteme H, Lövqvist A, Graf W, Lundqvist H, Carlsson J, Sundin A.
    Anticancer Res; 1998 Mar 01; 18(2A):843-8. PubMed ID: 9615730
    [Abstract] [Full Text] [Related]

  • 11. Dose escalation trial of indium-111-labeled anti-carcinoembryonic antigen chimeric monoclonal antibody (chimeric T84.66) in presurgical colorectal cancer patients.
    Wong JY, Chu DZ, Yamauchi D, Odom-Maryon TL, Williams LE, Liu A, Esteban JM, Wu AM, Primus FJ, Beatty JD, Shively JE, Raubitschek AA.
    J Nucl Med; 1998 Dec 01; 39(12):2097-104. PubMed ID: 9867150
    [Abstract] [Full Text] [Related]

  • 12. Comparison of copper-67- and iodine-125-labeled anti-CEA monoclonal antibody biodistribution in patients with colorectal tumors.
    Delaloye AB, Delaloye B, Buchegger F, Vogel CA, Gillet M, Mach JP, Smith A, Schubiger PA.
    J Nucl Med; 1997 Jun 01; 38(6):847-53. PubMed ID: 9189128
    [Abstract] [Full Text] [Related]

  • 13. Pilot trial evaluating an 123I-labeled 80-kilodalton engineered anticarcinoembryonic antigen antibody fragment (cT84.66 minibody) in patients with colorectal cancer.
    Wong JY, Chu DZ, Williams LE, Yamauchi DM, Ikle DN, Kwok CS, Liu A, Wilczynski S, Colcher D, Yazaki PJ, Shively JE, Wu AM, Raubitschek AA.
    Clin Cancer Res; 2004 Aug 01; 10(15):5014-21. PubMed ID: 15297402
    [Abstract] [Full Text] [Related]

  • 14. The intraportal injection model for liver metastasis: advantages of associated bioluminescence to assess tumor growth and influences on tumor uptake of radiolabeled anti-carcinoembryonic antigen antibody.
    Frampas E, Maurel C, Thedrez P, Remaud-Le Saëc P, Faivre-Chauvet A, Barbet J.
    Nucl Med Commun; 2011 Feb 01; 32(2):147-54. PubMed ID: 21116205
    [Abstract] [Full Text] [Related]

  • 15. Radioimmunotherapy of carcinoma of colon with [131I]-labeled recombinant chimeric monoclonal antibodies to carcinoembryonic antigen.
    Lu QJ, Bian GX, Chen YY, Zhang M, Guo SM, Wen LQ.
    Acta Pharmacol Sin; 2005 Oct 01; 26(10):1259-64. PubMed ID: 16174444
    [Abstract] [Full Text] [Related]

  • 16. Localization of radiolabeled anti-CEA antibody in subcutaneous and intrahepatic colorectal xenografts: influence of tumor size and location within host organ on antibody uptake.
    Dearling JL, Flynn AA, Qureshi U, Whiting S, Boxer GM, Green A, Begent RH, Pedley RB.
    Nucl Med Biol; 2009 Nov 01; 36(8):883-94. PubMed ID: 19875045
    [Abstract] [Full Text] [Related]

  • 17. Ablation of colorectal xenografts with combined radioimmunotherapy and tumor blood flow-modifying agents.
    Pedley RB, Boden JA, Boden R, Boxer GM, Flynn AA, Keep PA, Begent RH.
    Cancer Res; 1996 Jul 15; 56(14):3293-300. PubMed ID: 8764124
    [Abstract] [Full Text] [Related]

  • 18. Cure of metastatic human colonic cancer in mice with radiolabeled monoclonal antibody fragments.
    Behr TM, Blumenthal RD, Memtsoudis S, Sharkey RM, Gratz S, Becker W, Goldenberg DM.
    Clin Cancer Res; 2000 Dec 15; 6(12):4900-7. PubMed ID: 11156250
    [Abstract] [Full Text] [Related]

  • 19. Biodistribution and scintigraphic studies of 153Sm-labeled anti-CEA monoclonal antibody for radioimmunoscintigraphy and radioimmunotherapy.
    Fani M, Xanthopoulos S, Archimandritis SC, Stratis N, Bouziotis P, Loudos G, Varvarigou AD.
    Anticancer Res; 2003 Dec 15; 23(3A):2195-9. PubMed ID: 12894597
    [Abstract] [Full Text] [Related]

  • 20. Copper-67 radioimmunotherapy and growth inhibition by anti-L1-cell adhesion molecule monoclonal antibodies in a therapy model of ovarian cancer metastasis.
    Knogler K, Grünberg J, Zimmermann K, Cohrs S, Honer M, Ametamey S, Altevogt P, Fogel M, Schubiger PA, Novak-Hofer I.
    Clin Cancer Res; 2007 Jan 15; 13(2 Pt 1):603-11. PubMed ID: 17255283
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.